戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ed time schedules while also meeting current good manufacturing practice.
2 nt for serum albumin that is compatible with good manufacturing practice.
3  transplant products performed under current Good Manufacturing Practice.
4  recombinant biotherapeutics to standards of good manufacturing practice.
5 based radiolabeling procedure compliant with good manufacturing practices.
6 n IL-15 (rhIL-15) was produced under current good manufacturing practices.
7 5% were sold by US Web sites and 75% claimed Good Manufacturing Practices.
8 n Escherichia coli and purified according to good manufacturing practices.
9 implementing good agricultural practices and good manufacturing practices and applying existing toxic
10       The process was compliant with Current Good Manufacturing Practices and Current Good Tissue Pra
11   The method is readily adaptable to current good manufacturing practices and scale-up processes, and
12 model following current regulatory guidance, good manufacturing practice, and good clinical practice
13 nts for drug approval procedures and current good manufacturing practice, and the FDA has issued a dr
14 pplication requires upscaling, adaptation to good manufacturing practices, and determination of the e
15                        Obeying guidelines of good manufacturing practice, aroma carryover with no sen
16  II clinical trial evaluating the effects of good manufacturing practice-artesunate in patients with
17  II clinical trial evaluating the effects of good manufacturing practice-artesunate in patients with
18 sions from human volunteers by using Current Good Manufacturing Practice CD16 CliniMACS isolation, la
19 tree by protocols in accordance with current good manufacturing practice (cGMP) and extensively chara
20 iopharmaceuticals is conducted under current good manufacturing practice (cGMP) and involves multiple
21  organisms representative of the NIH current good manufacturing practice (cGMP) environment.
22 nagement, especially within academic current Good Manufacturing Practice (cGMP) facilities, where res
23 ance with regulatory commitments and current good manufacturing practice (cGMP) regulations.
24 yield and purity in concordance with current good manufacturing practice (cGMP) requirements.
25 ibe a process in accordance with the Current Good Manufacturing Practice (CGMP) to generate large-sca
26 d vaccine in a manner compliant with current Good Manufacturing Practice (cGMP).
27 CAR19 T cells are manufactured under current good manufacturing practices (cGMP) at two disparate cli
28 an overview of this complex field of current good manufacturing practices (cGMP) based on biopharmace
29 mg/16 mg) insert was confirmed under current Good Manufacturing Practices (cGMP) conditions.
30 llular therapy suites as part of the current good manufacturing practices (cGMP) environmental monito
31 ent good tissue practices (cGTP) and current good manufacturing practices (cGMP) for the manufacturin
32 cs is challenged by the high cost of current Good Manufacturing Practices (cGMP) production.
33 n such tests because they fall under current Good Manufacturing Practices (cGMP) regulated by the Uni
34 passages were carried out using U.S. current Good Manufacturing Practices (cGMP) to produce the Vacci
35 ylated cetuximab in conjunction with current good manufacturing practices (cGMP)-grade anti-biotin im
36                Single-step production from a Good Manufacturing Practice cold kit may enable rapid ad
37 n applications such as cell therapies, where good manufacturing practice compatibility is of paramoun
38  a simple, defined, efficient, scalable, and good manufacturing practice-compatible 3D culture system
39 egs via repetitive CD3/CD28 stimulation in a good manufacturing practice-compatible expansion system.
40 aque EHM model with a previously established Good Manufacturing Practice-compatible human EHM formula
41                      This work establishes a Good Manufacturing Practice-compatible manufacturing pro
42     ATDC preparations were manufactured in a Good Manufacturing Practice-compliant facility and fulfi
43 e of PIV3-specific T cells produced with our Good Manufacturing Practice-compliant manufacturing proc
44         The study aims were (1) to develop a Good Manufacturing Practice-compliant method of labeling
45         Following in vitro expansion using a good manufacturing practice-compliant methodology (desig
46 e results highlight the development of a new Good Manufacturing Practice-compliant platform for gener
47                      A practical and current good manufacturing practice-compliant preparation of rad
48 (18)F]MFBG was produced in a fully automated good manufacturing practice-compliant procedure.
49 ve therapies that could be integrated into a good manufacturing practice-compliant process.
50 enitor cell use for burn wound treatment and Good Manufacturing Practice-compliant technology transfe
51                    The in vivo properties of good manufacturing practice-compliant, newly developed k
52                                     Further, Good Manufacturing Practices-compliant products are expe
53 )Cu-LLP2A was synthesized in accordance with good-manufacturing-practice-compliant procedures.
54 plementation of (18)F-UCB-H production under good manufacturing practice conditions and the first hum
55 ol is scalable for production of mDAPs under good manufacturing practice conditions and was also prev
56 developed and compiled in a kit system under good manufacturing practice conditions with standardized
57 -T cells were effectively manufactured under Good Manufacturing Practice conditions, with a reduced r
58 in 3 validation runs performed under current good manufacturing practice conditions.
59  cell lines including one reprogrammed under good manufacturing practice conditions.
60 he use of components compatible with current good manufacturing practice could make this vaccine tech
61 ET, with (18)F-FDS synthesized using current good manufacturing practice, could rapidly differentiate
62  an experimental radiosynthesis to a current good manufacturing practice environment is challenging.
63  ecosystem, manufacture products in academic good manufacturing practice facilities and work closely
64 ed from harvested tumor specimens in central Good Manufacturing Practice facilities using a streamlin
65 s study was conducted at a university-based, good manufacturing practice facility and academic ophtha
66 rogress and clinical cell manufacturing in a Good Manufacturing Practice facility.
67  pancreases of those patients at our current good manufacturing practice facility.
68 he iliac crest, and MNCs were separated at a Good Manufacturing Practices facility and administered i
69 ticated ex vivo gene transfer in a dedicated Good Manufacturing Practices facility, limiting availabi
70  membrane with rigorous quality control in a good manufacturing practices facility.
71 art 212 regarding the regulations on current good manufacturing practice for PET drugs.
72  accordance with the regulations for current good manufacturing practices for PET drugs (title 21, Co
73 he production of eggs is easily scalable and good manufacturing practices for therapeutics from eggs
74 nclude industrial scale-up or scale-down and good manufacturing practices, funding and navigating the
75 nd technical components, that we set to meet good manufacturing practice (GMP) and UK regulatory body
76  independent lots of clinical material under good manufacturing practice (GMP) conditions.
77 , about 50 lines have been established under Good Manufacturing Practice (GMP) conditions.
78          Using these markers, we developed a good manufacturing practice (GMP) differentiation protoc
79 d ex vivo using electroporation and requires good manufacturing practice (GMP) facilities, similar to
80  for CGT manufacturing, hosting a variety of good manufacturing practice (GMP) facilities.
81          This approach, if integrated into a good manufacturing practice (GMP) framework, could resul
82  manufacturing and clinical assessment under good manufacturing practice (GMP) guidelines.
83                     This Env is currently in good manufacturing practice (GMP) production to be made
84 combined with efficient cryopreservation and good manufacturing practice (GMP)-compatible culture, ma
85                        Finally, we develop a good manufacturing practice (GMP)-compatible process for
86 sferred the ATDC manufacturing protocol to a Good Manufacturing Practice (GMP)-compliant facility.
87 erived MSCs) is produced using an optimized, good manufacturing practice (GMP)-compliant manufacturin
88    A reference vaccine virus was produced in Good Manufacturing Practice (GMP)-grade facilities in le
89              A reverse genetics, cell-based, Good Manufacturing Practice (GMP)-produced, wild-type A(
90 d should be manufactured to the standards of good manufacturing practice (GMP).
91  from blood or leukapheresis, expanded under good manufacturing practices (GMP) conditions, and admin
92 n (AUC) closer to a possible validation in a Good Manufacturing Practices (GMP) environment.
93                                  The central Good Manufacturing Practices (GMP) facility produced suf
94        The manufacturing process aligns with good manufacturing practices (GMP) guidelines, including
95  a lack of suitable software compatible with Good Manufacturing Practices (GMP) has hampered the use
96 eerythrocyte-stage protein, we undertook the good manufacturing practices (GMP) manufacture of a reco
97     Seven centers using, and one developing, Good Manufacturing Practices (GMP) processes were survey
98 ile also revealing gaps in long-term safety, Good Manufacturing Practices (GMP), and regulation.
99            Successful clinical scale-up in a good manufacturing practices (GMP)-compliant bioreactor
100  aimed to develop a simple, fully automated, good-manufacturing-practice (GMP)-compliant production p
101                                            A good-manufacturing-practices (GMP) (68)Ge/(68)Ga generat
102 His6 Nanobody and the lead optimized current-good-manufacturing-practice grade analog 2Rs15d were con
103        Clinical-grade DCs were infected with good manufacturing practice-grade ALVAC-HIV vaccine cons
104 om 4 patients with RDEB were transduced with good manufacturing practice-grade retrovirus carrying fu
105 ngle production site operating under typical good manufacturing practice guidelines.
106 with a fully automated process conforming to good-manufacturing-practice guidelines, in view of its c
107 erformed on the product according to current good manufacturing practice, including radionuclidic ide
108 l dietary supplements must be produced using good manufacturing practice is an important step toward
109 ese highly purified vaccines, produced under good manufacturing practice-like conditions, to decipher
110              This paves the way for proposed good manufacturing practices manufacture and clinical tr
111 idation set samples were tested with current good manufacturing practices-manufactured reagents after
112 erentiated hESCs using clinically acceptable good manufacturing practices must be developed.
113   In addition, PRINT is a GMP-compliant (GMP=good manufacturing practice) platform amenable for parti
114 of a multistep continuous-flow CGMP (current good manufacturing practices) process that produced 24 k
115 ngle dose of a cell-based, reverse-genetics, Good Manufacturing Practices-produced wild-type influenz
116                                    A current Good Manufacturing Practice product of WRSd1 given intra
117  C Env gp145 protein is currently undergoing good manufacturing practice production for use as a reag
118 he half-life of (64)Cu would also facilitate good-manufacturing-practice production and distribution
119                                         GMP (Good Manufacturing Practice) production requirements and
120 rogels, serum-free media, and densely seeded good manufacturing practice protocol-grade human neural
121 tion were adapted to substances available in good manufacturing practice quality.
122 ranasal co-delivery of miR-18a and NEO100, a good manufacturing practices-quality form of perillyl al
123                                              Good manufacturing practice regulations should be used b
124  to quality control release or under current good manufacturing practices regulations enforced by reg
125 the imposition of industry standards such as Good Manufacturing Practice requirements.
126 ial, where human AFSC-EVs obtained following good manufacturing practices restored pulmonary epitheli
127 s could be generated in chimpanzee plasma by good manufacturing practice using CD14(+) mononuclear pr
128                                  Adhering to good manufacturing practice, we have developed a new (99
129 supplier, rasa shastra status, and claims of Good Manufacturing Practices were recorded.
130 c stem cells, meeting release criteria under Good Manufacturing Practice, were delivered by endomyoca

 
Page Top